Burkina Faso vs Yemen: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
Yemen
3.85 million
in 2024
Burkina Faso rank
19th
Yemen rank
21st
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- Yemen
How they compare
Burkina Faso currently reports 4.46 million against 3.85 million in Yemen, a difference of 613,160.
That makes Burkina Faso's figure about 1.2 times Yemen's.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Yemen ahead.
Burkina Faso ranks 19th and Yemen ranks 21st of 52 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million | 6.08 million | 2.21 million | Yemen |
| 2020s | 3.48 million | 3.75 million | 272,092 | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or Yemen?
- Burkina Faso, at 4.46 million against 3.85 million in Yemen as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and Yemen?
- 613,160, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Yemen?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Yemen rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.